<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">31092</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial article</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Передовая статья</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Crystalline histiocytosis</article-title><trans-title-group xml:lang="ru"><trans-title>Кристаллический гистиоцитоз</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rekhtina</surname><given-names>I G</given-names></name><name xml:lang="ru"><surname>Рехтина</surname><given-names>И Г</given-names></name></name-alternatives><email>rekhtina@blood.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Golitsyna</surname><given-names>E P</given-names></name><name xml:lang="ru"><surname>Голицына</surname><given-names>Е П</given-names></name></name-alternatives><email>e.p.golicina@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Varshavskiĭ</surname><given-names>V A</given-names></name><name xml:lang="ru"><surname>Варшавский</surname><given-names>В А</given-names></name></name-alternatives><email>Vavarsh@mmscience.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kaplanskaia</surname><given-names>I B</given-names></name><name xml:lang="ru"><surname>Капланская</surname><given-names>И Б</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Glasko</surname><given-names>E N</given-names></name><name xml:lang="ru"><surname>Гласко</surname><given-names>Е Н</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fominykh</surname><given-names>E S</given-names></name><name xml:lang="ru"><surname>Фоминых</surname><given-names>Е С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Biriukova</surname><given-names>L S</given-names></name><name xml:lang="ru"><surname>Бирюкова</surname><given-names>Л С</given-names></name></name-alternatives><email>birjukova@blood.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ФГБУ "Гематологический научный центр" Минздравсоцразвития России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-07-15" publication-format="electronic"><day>15</day><month>07</month><year>2012</year></pub-date><volume>84</volume><issue>7</issue><issue-title xml:lang="en">VOL 84, NO7 ()</issue-title><issue-title xml:lang="ru">ТОМ 84, №7 (2012)</issue-title><fpage>75</fpage><lpage>78</lpage><history><date date-type="received" iso-8601-date="2020-04-10"><day>10</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/31092">https://ter-arkhiv.ru/0040-3660/article/view/31092</self-uri><abstract xml:lang="en"><p>The paper describes a case of diagnosis of the rare monoclonal secretion-associated disease crystalline histiocytosis with kidney and bone marrow involvement. The female patient with multiple myeloma (MM) was found to have intralysosomal crystals in the cells of the bone marrow (histiocytes, plasmocytes), kidneys proper (mesangiocytes, podocytes), and subsequently in those of a kidney graft. Lower secreted monoclonal IgG and ceased Bence-Jones protein secretion after MM chemotherapy were accompanied by improved and stabilized kidney graft function. However, a repeat morphological study of a renal biopsy specimen showed that the crystalline inclusions were preserved in the podocytes. By comparing the immunological and renal responses, it is reasonable to suggest that monoclonal IgG rather than Bence-Jones protein is of value in the pathogenesis of crystal formation.</p></abstract><trans-abstract xml:lang="ru"><p>Аннотация. Представлен случай диагностики редкого заболевания, ассоциированного с моноклональной секрецией, - кристаллического гистиоцитоза с поражением почек и костного мозга. У больной множественной миеломой (ММ) были обнаружены внутрилизосомально расположенные кристаллы в клетках костного мозга - КМ (гистиоцитах, плазмоцитах), собственных почках (мезангиоцитах, подоцитах), в последующем - в клетках почечного трансплантата.Уменьшение секретируемого моноклонального IgG и прекращение секреции белка Бенс-Джонса после химиотерапии ММ сопровождалось улучшением и стабилизацией функции почечного трансплантата. Однако при повторном морфологическом исследовании нефробиоптата сохранялись кристаллические включения в подоцитах. Сопоставляя иммунохимический и ренальный ответы, правомочно предположить, что в патогенезе формирования кристаллов имеет значение моноклональный IgG, а не белок Бенс-Джонса.</p></trans-abstract><kwd-group xml:lang="en"><kwd>multiple myeloma</kwd><kwd>crystalline histiocytosis</kwd><kwd>nephropathy</kwd><kwd>monoclonal gammapathy</kwd><kwd>kidney graf</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>множественная миелома</kwd><kwd>кристаллический гистиоцитоз</kwd><kwd>нефропатия</kwd><kwd>моноклональная гаммапатия</kwd><kwd>трансплантат почк</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Lebeau A., Zeindl-Eberhart E., Muller E.C. et al. Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of literature. Blood 2002; 5: 1817-1827.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Hamel C.E., Thierry A., Trouillas P. et al. Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome. Nephrol Dial Transplant 2010; 25: 2982-2990.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Papla B., Spólnik P., Rzenno E. et al. Generalized crystal-storing histiocytosis as a presentation of multiple myeloma: a case with a possible pro-aggregation defect in the immunoglobulin heavy chain. Virchows Arch 2004; 445: 1: 83-89.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Jones D., Bhatia V.K., Krausz T., Pinkus G.S. Crystalstoring histiocytosis: A disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chains. Hum Pathol 1999; 30: 1441-1448.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Schaefer H.E. Gammopathy-related crystal-storing histiocytosis, pseudo- and pseudo- pseudo-Gaucher cells. Critical commentary and mini-reviw. Pathol Res Pract 1996; 192: 1152-1162.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Papo T., Musset L., Bardin T. et al. Cryocrystalglobulinemia as a cause of systemic vasculopathy and widespread erosive arthropathy. Arthr Rheum 1996; 39: 335-340.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Lee D.B., Drinkard J.P., Rosen V.J., Gonick H.C. The adult Fanconi syndrome: observations on etiology, morphology, renal function and mineral metabolism in three patients. Medicine 1972; 51: 107-138.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Sethi S., Cuiffo B., Pinkus G., Rennke H. Crystal-storing histiocytosis involving the kidney in a low-grade B-cell lymphoproliferative disorder. Am J Kidney Dis 2002; 39 (1): 183-188.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hirota S., Miyamoto M., Kasagui T. et al. Crystalline light chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma. Arch Pathol Lab Med 1990; 114: 429-431.</mixed-citation></ref></ref-list></back></article>
